CAW
REGN icon

Cornerstone Advisors (Washington)’s Regeneron Pharmaceuticals REGN Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-791
Closed -$248K – 1244
2019
Q2 		$248K Sell
791
-51
-6% -$17K 0.02% 116
2019
Q1 		$346K Buy
842
+30
+4% +$12.4K 0.03% 76
2018
Q4 		$303K Buy
812
+136
+20% +$49.8K 0.05% 78
2018
Q3 		$273K Buy
676
+9
+1% +$3.42K 0.18% 90
2018
Q2 		$230K Sell
667
-1
-0.1% -$313 0.16% 104
2018
Q1 		$230K Buy
668
+22
+3% +$7.65K 0.16% 102
2017
Q4 		$243K Sell
646
-77
-11% -$31.2K 0.16% 90
2017
Q3 		$323K Sell
723
-20
-3% -$9.52K 0.22% 68
2017
Q2 		$365K Sell
743
-90
-11% -$39.4K 0.2% 54
2017
Q1 		$323K Buy
833
+165
+25% +$61.2K 0.18% 62
2016
Q4 		$245K Buy
668
+20
+3% +$7.61K 0.21% 74
2016
Q3 		$261K Buy
648
+305
+89% +$122K 0.22% 63
2016
Q2 		$120K Sell
343
-65
-16% -$25K 0.12% 90
2016
Q1 		$147K Buy
408
+18
+5% +$7.42K 0.15% 85
2015
Q4 		$212K Sell
390
-420
-52% -$228K 0.23% 53
2015
Q3 		$377K Sell
810
-30
-4% -$16.1K 0.33% 36
2015
Q2 		$429K Sell
840
-130
-13% -$63.4K 0.35% 40
2015
Q1 		$438K Hold
970
– – 0.34% 42
2014
Q4 		$398K Buy
970
+915
+1,664% +$360K 0.29% 54
2014
Q3 		$20K Sell
55
-4
-7% -$1.34K 0.02% 133
2014
Q2 		$17K Hold
59
– – 0.02% 161
2014
Q1 		$18K Buy
+59
New +$18.2K 0.02% 144

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Cornerstone Advisors (Washington)'s REGN Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Regeneron Pharmaceuticals (REGN) in Q3 2019, closing a stake of 791 shares — an estimated $248K sold.

Cornerstone Advisors (Washington) first reported a position in REGN in Q1 2014 and held it in 22 quarters. The position peaked at $438K in Q1 2015. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Regeneron Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 791 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $248K.
  • Cornerstone Advisors (Washington) first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 22 quarters.
  • Cornerstone Advisors (Washington)'s Regeneron Pharmaceuticals position peaked at $438K in Q1 2015.
  • 633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.